Sign in
4

Changes in Ownership

Prelude Therapeutics Inc Filed Acc 0001209191-21-029351

EVP, Chief of Clinical Affairs sold 3,223 shares at $40.29 ($129,853)

  • EVP, Chief of Clinical Affairs acquired 3,223 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Morosini Deborah EVP, Chief of Clinical Affairs 2021-04-29 Option exercise +3,223 $1.89 $6,091 3,667 D
Morosini Deborah EVP, Chief of Clinical Affairs 2021-04-29 Sale −3,223 $40.29 $129,853 444 D
Derivatives
Morosini Deborah EVP, Chief of Clinical Affairs 2021-04-29 Option exercise · Employee Stock Option (right to buy) −3,223 4,323 D
Open-market sales · 3,223 sh · avg $40.29 · $129,853
Loading xslF345X03/doc4.xml…